Table 2.
Patient baseline characteristics (safety set)
| N | Pubertal/prepubertal, % | Mean (range) age, years | Mean (SD) BMI SDS | Mean (SD) HSDS | Mean (SD) HVa, cm/year | Mean (SD) PC HVSDS | |
|---|---|---|---|---|---|---|---|
| All | 348 | 9.8/90.2 | 8.96 (0.7–18.5) | 0.31 (1.18) | −2.78 (1.14) | 3.60 (1.82) | −2.43 (2.38) |
|
| |||||||
| rhGH naïve | 284 | 6.0/94.0 | 8.54 (0.7–18.5) | 0.20 (1.18) | −3.00 (1.03) | 3.39 (1.68) | −3.08 (1.85) |
| Pretreated | 64 | 26.6/73.4 | 10.84 (2.9–18.0) | 0.81 (1.02) | −1.80 (1.12) | 3.99 (2.00) | −1.23 (2.78) |
AH, adult height; HV, height velocity; HSDS, height standard deviation score; SD, standard deviation; HVSDS, HV standard deviation score; PC, peak-centered; rhGH, recombinant human growth hormone.
a
Only for patients who had not attained AH.